Cannabis: Mental-Health Warning!
Tuesday 29 March 2016
white-coat-poet: The Attic Window
white-coat-poet: The Attic Window: Anne Frank House, Amsterdam Peter puts his hand in mine as we stare at the world through the window. We can hear the wind-- what breaths...
Friday 8 January 2016
March 1st, 2011 in Medicine &
Health / Psychology & Psychiatry
Cannabis use during adolescence and
young adulthood increases the risk of psychotic symptoms, while continued
cannabis use may increase the risk for psychotic disorder in later life,
concludes a new study published in the British Medical Journal today.
Cannabis is the most commonly used illicit drug in the world,
particularly among adolescents, and is consistently linked with an increased
risk for mental illness. However, it is not clear whether the link between
cannabis and psychosis is causal, or whether it is because people with
psychosis use cannabis to self medicate their symptoms.
So a team of researchers, led by Professor Jim van Os from Maastricht
University in the Netherlands, set out to investigate the association between
cannabis use and the incidence and persistence of psychotic symptoms over 10
years.
The study took place in Germany and involved a random sample of 1,923
adolescents and young adults aged 14 to 24 years.
The researchers excluded anyone who reported cannabis use or
pre-existing psychotic symptoms at the start of the study so that they could
examine the relation between new (incident) cannabis use and psychotic
symptoms.
The remaining participants were then assessed for cannabis use and
psychotic symptoms at three time points over the study period (on average four
years apart).
Incident cannabis use almost doubled the risk of later incident
psychotic symptoms, even after accounting for factors such as age, sex,
socioeconomic status, use of other drugs, and other psychiatric diagnoses.
Furthermore, in those with cannabis use at the start of the study, continued
use of cannabis over the study period increased the risk of persistent psychotic
symptoms
There was no evidence for self medication effects as psychotic symptoms
did not predict later cannabis use.
These results "help to clarify the temporal association between
cannabis use and psychotic experiences," say the authors. "In addition,
cannabis use was confirmed as an environmental risk factor impacting on the
risk of persistence of psychotic experiences."
The major challenge is to deter enough young people from using cannabis
so that the prevalence of psychosis is reduced, say experts from Australia in
an accompanying editorial.
Professor Wayne Hall from the University of Queensland and Professor
Louisa Degenhardt from the Burnet Institute in Melbourne, question the UK's
decision to retain criminal penalties for cannabis use, despite evidence that
removing such penalties has little or no detectable effect on rates of use.
They believe that an informed cannabis policy "should be based not only on
the harms caused by cannabis use, but also on the harms caused by social
policies that attempt to discourage its use, such as criminal penalties for
possession and use."
Provided by British Medical Journal
"Cannabis use precedes the onset
of psychotic symptoms in young people." March 1st, 2011.
http://www.physorg.com/news/2011-03-cannabis-onset-psychotic-symptoms-young.html
http://www.physorg.com/news/2011-03-cannabis-onset-psychotic-symptoms-young.html
Synthetic cannabis linked to extended psychosis
May 18th, 2011 in Psychology & Psychiatry
Case studies indicate the recreational use of synthetic cannabis may lead to psychosis that can last for days or months in some cases, according to a study at the American Psychiatric Association Annual Meeting in Hawaii.
Researchers at the Naval Medical Center in San Diego followed ten patients hospitalized for psychosis apparently induced by the use of synthetic cannabis, commonly known as “Spice,” “K2,” “Blaze,” and “Red X Dawn.” These are plant material coated with varying combinations of synthetic cannabinoids, which act on the body in a similar way to chemicals found in cannabis. The compounds have not been approved by the FDA for human consumption and little is known about their safety.
The ten patients studied ranged in age from 21 to 25 years old and after use of “Spice” experienced ongoing psychotic symptoms, including auditory and visual hallucinations, paranoid delusions, odd or flat affect, thought blocking, disorganized speech, thoughts of suicide, insomnia, slowed reaction times, agitation and anxiety. Psychotic symptoms generally resolved between five and eight days after admission, but in some cases continued three months or longer.
The research was scheduled for presentation at 1 p.m. Saturday, May 14, at the American Psychiatric Association 164 the Annual Meeting, which runs May 14-18 at the Hawaii Convention Center in Honolulu.
Provided by American Psychiatric Association
"Synthetic cannabis linked to extended psychosis." May 18th, 2011. http://medicalxpress.com/news/2011-05-synthetic-cannabis-linked-psychosis.html
Molecular imaging shows chronic
marijuana smoking affects brain chemistry
June 6th, 2011 in Neuroscience
Definitive proof of an adverse effect
of chronic marijuana use revealed at SNM's 58th Annual Meeting could lead to
potential drug treatments and aid other research involved in cannabinoid
receptors, a neurotransmission system receiving a lot of attention. Scientists
used molecular imaging to visualize changes in the brains of heavy marijuana
smokers versus non-smokers and found that abuse of the drug led to a decreased
number of cannabinoid CB1 receptors, which are involved in not just pleasure,
appetite and pain tolerance but a host of other psychological and physiological
functions of the body.
"Addictions are a major medical and socioeconomic problem,"
says Jussi Hirvonen, MD, PhD, lead author of the collaborative study between
the National Institute of Mental Health and National Institute on Drug Abuse,
Bethesda, Md. "Unfortunately, we do not fully understand the
neurobiological mechanisms involved in addiction. With this study, we were able
to show for the first time that people who abuse cannabis have abnormalities of
the cannabinoid receptors in the brain. This information may prove critical for
the development of novel treatments for cannabis abuse. Furthermore, this
research shows that the decreased receptors in people who abuse cannabis return
to normal when they stop smoking the drug."
According to the National Institute on Drug Abuse, marijuana is the
number-one illicit drug of choice in America. The psychoactive chemical in
marijuana, or cannabis, is delta-9-tetrahydrocannabinol (THC), which binds to
numerous cannabinoid receptors in the brain and throughout the body when smoked
or ingested, producing a distinctive high. Cannabinoid receptors in the brain
influence a range of mental states and actions, including pleasure,
concentration, perception of time and memory, sensory perception, and
coordination of movement. There are also cannabinoid receptors throughout the
body involved in a wide range of functions of the digestive, cardiovascular,
respiratory and other systems of the body. Currently two subtypes of
cannabinoid receptors are known, CB1 and CB2, the former being involved mostly
in functions of the central nervous system and the latter more in functions of
the immune system and in stem cells of the circulatory system. For this study,
researchers recruited 30 chronic daily cannabis smokers who were then monitored
at a closed inpatient facility for approximately four weeks. The subjects were
imaged using positron emission tomography (PET), which provides information
about physiological processes in the body. Subjects were injected with a
radioligand, 18F-FMPEP-d2, which is a combination of a radioactive fluorine
isotope and a neurotransmitter analog that binds with CB1 brain receptors.
Results of the study show that receptor number was decreased about 20
percent in brains of cannabis smokers when compared to healthy control subjects
with limited exposure to cannabis during their lifetime. These changes were
found to have a correlation with the number of years subjects had smoked. Of
the original 30 cannabis smokers, 14 of the subjects underwent a second PET
scan after about a month of abstinence. There was a marked increase in receptor
activity in those areas that had been decreased at the outset of the study, an
indication that while chronic cannabis smoking causes downregulation of CB1
receptors, the damage is reversible with abstinence. Information gleaned from
this and future studies may help other research exploring the role of PET
imaging of CB1 receptors—not just for drug use, but also for a range of human
diseases, including metabolic disease and cancer.
More information: Scientific Paper 10: J. Hirvonen, R. Goodwin, C. Li1, G. Terry, S.
Zoghbi, C Morse, V. Pike, N. Volkow, M. Huestis, R. Innis, National Institute
of Mental Health, Bethesda, MD; National Institute on Drug Abuse, Baltimore,
MD; "Reversible and regionally selective downregulation of brain
cannabinoid CB1 receptors in chronic daily cannabis smokers," SNM's 58th
Annual Meeting, June 4-8, 2011, San Antonio, TX.
Provided by Society of Nuclear Medicine
"Molecular imaging shows chronic marijuana smoking affects brain
chemistry." June 6th, 2011.
Drinking,
cannabis use and psychological distress increase, CAMH survey finds
June 13th, 2011 in Health
The latest survey of Ontario adults
from the Centre for Addiction and Mental Health (CAMH) shows increasing rates
of daily drinking and cannabis use and high levels of psychological distress.
The results of the 2009 CAMH Monitor survey, the longest running survey
tracking mental health and addiction indicators among adults in Ontario, were
published today.
Alcohol:- The
proportion of adults reporting daily drinking increased from 5.3% in 2002 to
over 9% in 2009. The average number of drinks consumed weekly among drinkers
has also increased from 3 drinks to 4.6 drinks, and the proportion of adults
exceeding low-risk drinking guidelines remains at elevated levels (22%).
However, there were also some encouraging findings: there was a significant
decline in binge drinking from 12.6% in 2006 to 7.1% in 2009, and the decline
was evident especially among young adults, from 24% to 11.5%. Although driving
within an hour of consuming two or more drinks has shown a steady decline in
the past years, from 13.1% in 1996 to 6.9% in 2009, there is evidence that this
trend has reversed among young adults. Driving after drinking posted a
significant increase among 18 to 29 year olds, from 7.7% in 2005 to 12.8% in
2009. "The data tell us that while the number of people who drink alcohol
has not changed, the way they are drinking has -- people are drinking more
often and may be consuming more alcohol when they do drink, although there may
be fewer binge occasions," said Dr. Robert Mann, CAMH Senior Scientist and
lead investigator on the study. "We know that the more access people have
to alcohol, the more people will drink, leading to more instances of drinking
and driving. Measures such as Random Breath Testing and lowering legal limits
to .05% can reduce drunk driving deaths. The implementation of .05% legislation
in British Columbia appears to have resulted in a 50% decrease in drinking and
driving deaths in that province."
Cannabis:- The prevalence of cannabis use has been steadily increasing from 8.7% in
1996 to 13.3% in 2009, for both men and women and among all age groups. Along
with this, there was almost a 2-fold increase in cannabis use among those aged
18-29, from 18.3% to 35.8%. "These increases are of concern to us,"
stated Dr. Mann. "We know that cannabis use may increase the risk of
psychosis for people who are predisposed to schizophrenia, and may worsen the
symptoms of other mental illnesses." Another noticeable change was the
large increase in use of cannabis among older adults. Use by those aged 50
years and older increased more than 3-fold from 1.4% to 4.7% between 1996 and
2009 and, among past year cannabis users, the proportion of users aged 50 years
and older increased from 1.9% to 13.9% during the same time period.
Tobacco:- Some positive findings are that the percentage of adult Ontarians
reporting smoking cigarettes declined from 19.7% in 2008 to 18.6% in 2009.
Though 14% of Ontarians still report daily smoking, it is a positive sign that
cigarette smoking has steadily declined since 1996, from 26.8% to 18.6% in
2009. Dr. Mann notes that the provincial government's commitment to anti-
smoking legislation through smoke-free Ontario probably played an important
role in the decrease in smoking rates.
Mental Health:- One in seven Ontario adults (14.7%), representing 1,400,000 people,
reported symptoms of elevated psychological distress, and almost 6% reported
that their overall mental health was poor. Those aged 30-39 were the most
likely to report poor mental health, and those over age 65 reported the lowest
rates of poor mental health. Mental health was strongly correlated with
education. Those who had not graduated high school reported higher levels of
poor mental health, and those who had graduated from university reported lower
rates. "These results suggest that the social determinants of health, such
as income, play as important a role in mental health as they do in physical
health," said Mann. The use of anti-anxiety medication has remained stable
over the past few years, but trend data shows that over the past 10 years, use
of these medications has risen from 4.5% to nearly 7% of Ontario adults. The
same pattern can also be seen in the use of antidepressant medication, which
has trended upward from 3.6% in 1999 to the current rate of 6.6%. Added Dr.
Mann, "Though these are marked increases, they may also be showing that
more people experiencing mental health problems are seeking and receiving help,
which is a positive step." Despite several differences, there was no
strong dominant pattern in regional differences. Those from Northern Ontario
were the most likely to be current smokers and to smoke daily; those from
Toronto were the least likely to drink alcohol; those from the South West
region of the province reported the highest average number of drinks consumed
per week; and driving after drinking was most likely in the South West and in
the Central South regions. Provided by Centre for Addiction and Mental Health: "Drinking,
cannabis use and psychological distress increase, CAMH survey finds." June
13th, 2011.
How cannabis causes 'cognitive chaos'
in the brain
October 25th, 2011 in Neuroscience
Cannabis use is associated with
disturbances in concentration and memory. New research by neuroscientists at
the University of Bristol, published in the Journal of Neuroscience,
has found that brain activity becomes uncoordinated and inaccurate during these
altered states of mind, leading to neurophysiological and behavioural
impairments reminiscent of those seen in schizophrenia.
The collaborative study, led by Dr Matt Jones from
the University's School of Physiology and Pharmacology, tested whether the
detrimental effects of cannabis on memory and cognition could be the result of
'disorchestrated' brain networks.
Brain activity can be compared to performance of a
philharmonic orchestra in which string, brass, woodwind and percussion sections
are coupled together in rhythms dictated by the conductor. Similarly, specific
structures in the brain tune in to one another at defined frequencies: their
rhythmic activity gives rise to brain waves, and the tuning of these brain
waves normally allows processing of information used to guide our behaviour.
Using state-of-the-art technology, the researchers
measured electrical activity from hundreds of neurons in rats that were given a
drug that mimics the psychoactive ingredient of marijuana. While the effects of
the drug on individual brain regions were subtle, the drug completely disrupted
co-ordinated brain waves across the hippocampus and prefrontal cortex, as
though two sections of the orchestra were playing out of synch.
Both these brain structures are essential for
memory and decision-making and heavily implicated in the pathology of
schizophrenia.
The results from the study show that as a
consequence of this decoupling of hippocampus and prefrontal cortex, the rats
became unable to make accurate decisions when navigating around a maze.
Dr Jones, lead author and MRC Senior Non-clinical
Fellow at the University, said: "Marijuana abuse is common among sufferers
of schizophrenia and recent studies have shown that the psychoactive ingredient
of marijuana can induce some symptoms of schizophrenia in healthy volunteers.
These findings are therefore important for our understanding of psychiatric
diseases, which may arise as a consequence of 'disorchestrated brains' and
could be treated by re-tuning brain activity."
Michal Kucewicz, first author on the study, added:
"These results are an important step forward in our understanding of how
rhythmic activity in the brain underlies thought processes in health and
disease."
Provided by University of Bristol
"How cannabis causes 'cognitive
chaos' in the brain." October 25th, 2011.
http://medicalxpress.com/news/2011-10-cannabis-cognitive-chaos-brain.html
http://medicalxpress.com/news/2011-10-cannabis-cognitive-chaos-brain.html
Cannabis harms the brain - but that's
not the full story
December 12th, 2011 in Psychology &
Psychiatry
(Medical Xpress) -- For the first time,
scientists have proven that cannabis harms the brain. But the same study
challenges previously-held assumptions about use of the drug, showing that some
brain irregularities predate drug use.
Professor Dan Lubman, from Turning Point Alcohol and Drug Centre and
Monash University, along with a team of researchers from Melbourne
University have conducted a world-first study examining whether these brain
abnormalities represent markers of vulnerability to cannabis use.
“Previous evidence has shown that long-term heavy cannabis use is
associated with alterations in regional brain volumes,” Professor Lubman said.
“Although these changes are frequently attributed to the neurotoxic
effects of cannabis, no studies have examined whether structural brain
abnormalities are present before the onset of cannabis use until now.”
To fill this void in present studies, Professor Lubman and his team
recruited participants from primary schools in Melbourne, Australia, as part of
a larger study examining adolescent emotional development.
Of the 155 original participants who underwent structural magnetic
resonance imaging at age 12, 121 completed a follow-up survey measuring substance
use four years later. It was found that by age 16, 28 participants had
commenced using cannabis.
“This is an important developmental period to examine, because although
not all individuals who initiate cannabis use during this time will go on to
use heavily, early cannabis use has been associated with a range of negative
outcomes later in life,” Professor Lubman said.
Their findings revealed that youth with smaller orbitofrontal cortex
(OFC) volumes, part of the frontal lobe of the brain, at age 12 were more
likely to have initiated cannabis use by age 16. The volumes of other regions
of the brain did not predict later cannabis use.
“Given the lack of research in this area, we hypothesised that pre-drug
use differences would be consistent with the structural abnormalities that have
been found in studies of heavy users,” Professor Lubman said.
“What we found is that only the OFC predicted later cannabis use,
suggesting that this particular part of the frontal lobe increases an
adolescent’s vulnerability to cannabis use. However, we also found no
differences in brain volume in other parts of the brain that we have shown to
be abnormal in long-term heavy cannabis users, confirming for the first time,
that cannabis use is neurotoxic to these brain areas in humans.” The OFC plays
a primary role in inhibitory control and reward-based decision making; previous
studies of adolescent cannabis users have demonstrated subtle deficits in
problem-solving, attention, memory and executive functions. “In adult cannabis
users, decreased activation of the OFC has been associated with faulty
decision-making, suggesting that a reduced ability to weigh the pros and costs
of one’s actions might render certain individuals more prone to drug problems,”
Professor Lubman said. “These results have important implications for
understanding neurobiological predictors of cannabis use, but further research
is still needed to understand their relationships with heavier patterns of use
in adulthood as well as later abuse of other substances.”
This research has been published online in Biological Psychiatry,
the official journal of the Society of Biological Psychiatry. Provided
by Monash University "Cannabis harms the brain - but that's not the full
story." December 12th, 2011. http://medicalxpress.com/news/2011-12-cannabis-brain-full-story.html
Subscribe to:
Posts (Atom)